Home > Boards > US OTC > Delisted > Alternus Energy Inc. (fka ALTND)

Looking for a consolidation here before move up

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
roman1 Member Profile
 
Followed By 1
Posts 39
Boards Moderated 0
Alias Born 10/16/09
160x600 placeholder
Medtronic Plc Down Over 5%, On Pace for Largest Percent Decrease Since June 2020 -- Data Talk
Medtronic Plc (MDT) is currently at $121.25, down $6.50 or 5.09% -- Would be lowest close since April 8, 2021, when it closed at $120.65
Ionis Pharma Shares Drop 12% After Tofersen Study Misses Primary Endpoint
Interactive Brokers Launches Cryptocurrency Trading
Molecular Templates: Vertex Terminates Collaboration
Omeros Shares Tumble as FDA Turns Away Narsoplimab Application
U.S. Home-Builder Sentiment Rose in October on Strong Demand -NAHB
U.S. Industrial Production Fell in September as Supply-Chain Woes, Ida Hit Activity
Becton, Dickinson Unveils ESG Strategy for 2030
Avidity Biosciences Lead Program Gets FDA Fast-Track Designation
Maserati Postpones Launch of New SUV as Chip Shortages Bite
Southern Names Former NRC Chairman Svinicki to Board
Top Company News of the Day
VC Daily: Is This VC Cycle Virtuous or Vicious?
Italy Faces Capital Demand of More Than $8 Billion to Sell Monte Dei Paschi -Reuters
Barkin Open to Fed Taper; China's GDP Growth Slows; No Break Seen From Supply-Chain Troubles
Thermo Fisher System Authorized for Covid-19 Saliva Testing
Amazon Aims to Hire 150,000 Seasonal Workers
Gilead Says FDA Approves Expanded Indication of Biktarvy for Treatment of HIV-1 in Pediatric Populations
Volkswagen's Skoda Halts Production for Fortnight Amid Supply Crunch
Intercontinental Exchange to Sell Euroclear Stake to Silver Lake
Adamis Pharmaceuticals Gets FDA Approval for Zimhi Injection Product
Enochian BioSciences Completes Pre-IND After FDA Comments
FTSE Down, Gilt Yields Hit Fresh Highs as Investors Bet on November Rate Rise
TD Bank Expects C$224 Million 4Q Contribution from Schwab Investment
Omeros Says FDA Needs More Information to Support Regulatory Approval for Narsoplimab
Oyster Point Pharma Gets FDA Approval for Dry Eye Disease Treatment
Investor AB Reports Negative Total Shareholder Return of 4% for 3Q
roman1   Thursday, 04/25/19 10:24:54 AM
Re: None
Post # of 27488 
Looking for a consolidation here before move up

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences